CASE HISTORY
The patient was a 42-year-old woman who was anaesthetised in 1981 for nasal polypectomy. Until 33 years of age she had no personal or family history of allergy. However, over the subsequent years she had experienced increasing asthma, rhinorrhoea, and coughing attacks. In 1978 she was found to have maxillary sinusitis and nasal and sinus polyps. In 1980 she underwent an uneventful polypectomy using diazepam, pentazocine, thiopentone, suxamethonium and halothane. Subsequent to the anaesthetic she had two asthmatic crises following acetysalicylic acid and "Hepatoum", a compound containing menthol and tartrazine. In January 1981 she was investigated by the Allergy Department. IgE was normal (97/Alml) and intradermal testing showed allergy to house mites and dust, and hyperreactivity to histamine (O.OI/Ag). Challenge tests were positive for menthol and negative for tartrazine. She was treated with theophylline, terbutaline, clorazepate, and thiophen nasal drops and syrup containing carboxycystein. The drops and syrup appeared to precipitate asthma.
In April 1981 she was admitted for polypectomy. She was treated for three days with tritoqualine 300 mg t.d.s., hydroxyzine 100 mg IM daily and tranexamic acid 100 mg t.d.s.
This pretreatment depletes histamine stores, impairs complement activation and saturates HI receptors.
One hour prior to surgery she was given an intragluteal injection of diazepam 10 mg, pentazocine 30 mg, dexamethasone 4 mg and atropine 0.5 mg. Anaesthesia was induced with diazepam 5 mg, pentazocine 15 mg, thiopentone 150 mg and she was paralysed with suxamethonium 60 mg. The cords were sprayed with 2070 lignocaine and she was intubated. It was impossible to ventilate her, so the tube was removed, checked and reinserted. Nebulized salbutamol had no effect and she became pale and hypotensive, although the electrocardiograph remained normal. She was given external cardiac massage, steroids, trisaminol, calcium chloride and metaraminol, and recovered in 60 minutes.
Eight weeks later she was investigated again. Intradermal testing was positive for pentazocine 1: 100 and suxamethonium 1: 1000. Human basophil degranulation tests 8 and Prausnitz-Klistner were negative for pentazocine, suxamethonium, diazepam, Anaesrhesia and Intensive Care, Vol. X, No. 2, May, 1982 lignocaine and thiopentone. A decrease in peak expiratory flow rate of 50070 was demonstrated with oral sodium benzoate 100 mg and 33070 with methylparahydroxybenzoate 10 mg.
DISCUSSION
We believe that this patient's reaction was due to sodium benzoate given with the diazepam. The total dose given to this patient was 96.7 mg intramusculary and 48 mg intravenously, a dose well in excess of the ingested dose producing bronchospasm. The parahydroxybenzoate in the lignocaine spray and dexamethasone may have played an additional role. In addition, intolerance to pentazocine has been described in a patient with idiosyncracy to aspirin. Intolerance to benzoate is well documented in chronic urticaria 9 and postulated in asthma. ID 10070 of asthmatics present the triad of intolerance to non-steroidal anti-inflammatory drugs, asthma, and nasal polyposis. 11 Of these 3-6070 show intolerance to benzoate. 12 -14 Patients with this triad may present for nasal polypectomy, and drugs presented in preparations containing benzoate (e.g. fentanyl, phenoperidine, multidose suxamethonium vials and diazepam) should be used with caution.
The pathomechanism of these reactions is different from that of anaphylaxis. Intradermal tests and basophil degranulation are negative, and the reactions occur in spite of histamine blockade suggesting histamine doses not play a predominant role. Tachycardia and cutaneous signs are absent.
We postulate that in patients with idiosyncrasy to non-steroidal anti-inflamatory drugs exposure to benzoates leads to reduced synthesis of PGE 2 which may induce cellular destabilisation with consequent histamine release. 15 ,16 In addition, benzoates and similar agents inhibit cyclo-oxygenase and cause increased release of slow reacting substance of anaphylaxisl7 (SRS-A), and may produce other leukotriens derived from arachidonic acid, especially C and D, which form SRS-A and may directly cause bronchoconstriction and vasodilatation, and also potentiate histamine release. IS In addition, in animals SRS-A activates the alternate pathway and induces bronchoconstriction by releasing C5a. 19 Histamint? blockade alone may be insufficient to prevent such reactions.
